CLINICAL_TRIALS
trial_result
· 2018-01-30
Clinical Trial Update: Lesinurad and Febuxostat Combination Extension Study in Gout [Phase 3]
Summary
Phase 3 trial update for a lesinurad and febuxostat combination in gout has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ardea Biosciences, Inc. | Conditions: Gout | Phase 3 | Status: COMPLETED | Results posted: 2018-01-30